REQUEST A DEMO
Total
USD $0.00
Search more companies

Genxone S.A. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Medical Equipment and Supplies Manufacturing | Medical and Diagnostic Laboratories
Full name: Genxone S.A. Profile Updated: November 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Genxone S.A. specialises in developing new products and solutions based on the latest technologies of nucleic acid sequencing, applying nanopore sequencing technology (third-generation of NGS) to many areas of science and business, including genetic diagnostics and the food industry. The company has one of the first ten laboratories in the world using nanopore sequencing technology and is a certified partner of Oxford Nanopore Technologies (ONT), a global leader in biotechnology innovation.

Headquarters
ul. Kobaltowa 6, Zlotniki
Suchy Las; Wielkopolskie; Postal Code: 62-002

Contact Details: Purchase the Genxone S.A. report to view the information.

Website: http://www.genxone.eu

Basic Information
Total Employees:
Purchase the Genxone S.A. report to view the information.
Outstanding Shares:
Purchase the Genxone S.A. report to view the information.
Registered Capital:
Purchase the Genxone S.A. report to view the information.
Financial Auditors:
Purchase the Genxone S.A. report to view the information.
Incorporation Date:
August 08, 2018
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Ownership Details
Purchase this report to view the information.
40.31%
Purchase this report to view the information.
12.96%
Purchase this report to view the information.
7.66%
Company Performance
Financial values in the chart are available after Genxone S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-52.1%
Total operating revenue
-52.13%
Operating profit (EBIT)
4.57%
EBITDA
12.9%
Net Profit (Loss) for the Period
-2.97%
Total assets
-22.99%
Total equity
-22.12%
Operating Profit Margin (ROS)
-131.35%
Net Profit Margin
-129.11%
Return on Equity (ROE)
-3.13%
Debt to Equity Ratio
-0.18%
Quick Ratio
2.5%
Cash Ratio
1.25%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?